MoneyWorks4Me

Biocon informs about press release

24 Jul 2023 Evaluate

Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.







Peers
Company Name CMP
Sun Pharma. Inds. 1783.40
Dr. Reddys Labs. 1197.40
Cipla 1332.90
Lupin 2014.75
Zydus Lifesciences 1145.50
View more..